To analyze the correlations between the presence of cirrhosis and hepatocellular inflammation and the serum concentrations of the amino-terminal peptide of procollagen type 111 in chronic liver disease, we measured prodlagen type 1 1 1 concentrations in paired serum samples from 46 patients (17 had
Procollagen-III peptide concentrations in serum of patients with chronic active hepatitis compared with mild hepatic disorders
✍ Scribed by Julio Collazos; Fernando Díaz
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 284 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0009-9120
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To evaluate the effect of interferon alfa (EN-a) on the hepatic extracellular matrix, we investigated the changes in serum N-terminal propeptide of type I11 procollagen during and after 4 months of INF-ru treatment in 178 treated and 45 nontreated patients with chronic hepatitis C. Serum pretreatmen
The peptide which is encoded by the pre-S(2) region of hepatitis B virus DNA, the pre-S(2) antigen, was determined quantitatively by an enzyme immunoassay system employing monoclonal antibodies. The prevalence and titer of pre-S(2)Ag were 91.9% (91/99) and 10,356 2 19,053 units (mean f S.D., arbitra
## Abstract Antibodies to the hepatitis C virus (HCV) core of various immunoglobulin classes were determined by enzyme immunoassays with three synthetic peptides, CP14 (amino acids 5‐40 of the core protein), CP10 (5‐23), and CP9 (39‐74). In 135 patients with chronic type C liver disease, anti‐CPU,
## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4